BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/92/0.1/20.09.24 | Market Closed - Deutsche Boerse AG 02:00:35 2024-07-04 pm EDT | ||
| 0.54 EUR | +12.50% |
|
| Current month | -8.47% | ||
| 1 month | +38.46% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-07-04 | 0.54 | +12.50% |
| 24-07-03 | 0.48 | +2.13% |
| 24-07-02 | 0.47 | +4.44% |
| 24-07-01 | 0.45 | -23.73% |
| 24-06-28 | 0.59 | -6.35% |
Delayed Quote Deutsche Boerse AG
Last update July 04, 2024 at 02:00 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VM9PQU |
| ISIN | DE000VM9PQU1 |
| Date issued | 2024-02-02 |
| Strike | 92 $ |
| Maturity | 2024-09-20 (78 Days) |
| Parity | 10 : 1 |
| Emission price | 0.33 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.09 € |
|---|---|
| Lowest since issue | 0.31 € |
| Spread | 0.04 € |
| Spread % | 6.90% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
91.08
USD
Average target price
96.13
USD
Spread / Average Target
+5.54%
- Stock Market
- Warrants
- Warrant
